# Astera Labs share price today (Astera Labs, Inc., ALAB)

> Astera Labs, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. ALAB · Technology · Semiconductors · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/alab

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $223.73 (+35.2% in a year)
- P/E: 88.3×, over 1 year
- Revenue (Jun 2026): $392 M (+104.5% on a year ago)
- Profit (Jun 2026): $153 M (+198.9% on a year ago)
- Operating margin: 22.7% (+2.0 points on a year ago)
- ROE: 16%, FY25

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Astera Labs share price today? Astera Labs, Inc.'s share price was $223.73 at the close on 4 November 2026. It has been moving sideways for 1 week. That is 12.6% below its average price over the last 200 trading days. In the last 52 weeks it traded between $112 and $417, and at that close it sat 37% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 12 weeks running. Over the last 2.6 years the share price moved +220% while the S&P 500 moved +47%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 14 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Astera Labs pay? Astera Labs, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Astera Labs on? Astera Labs is on 2 of our US lists: Nasdaq 100 companies and US tech stocks. - [Nasdaq 100 companies](https://www.sectoralpha.in/nasdaq-100-stocks)
- [US tech stocks](https://www.sectoralpha.in/us-tech-stocks)

## Is Astera Labs profitable? Astera Labs, Inc. earned $153 M of net profit in the Jun 2026 quarter, +198.9% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY25 profit was $219 M. That is 39.0% of the quarter's revenue. The same quarter a year earlier earned $51.2 M. 4 of the last 12 reported quarters were loss-making. Why profit moved: revenue changed +104.5% on a year earlier and the margin moved +2.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +144.4% and revenue +98.4%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Astera Labs make, and is it growing? Astera Labs, Inc. reported $392 M of revenue in the Jun 2026 quarter, +104.5% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 3 years it has grown 120.2% a year on average. The last full year, FY25, came in at $853 M. The last four reported quarters add to $1.2 B. FY25 revenue was $853 M, +115.1% on the year before. Recent pace: the last four quarters grew +98.4% on average, against 120.2% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +98.5%, against +128.8% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does Astera Labs keep? Astera Labs, Inc.'s operating margin was 22.7% in the Jun 2026 quarter, 2.0 percentage points higher than the same quarter a year ago. Across 4 years it has been between −75.4% and 20.3%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +2.0 percentage points on the year while gross margin changed −2.5 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Astera Labs' profit turning into cash? Astera Labs, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 it brought in $319 M of operating cash against $219 M of profit. After $37.5 M of spending on assets, $282 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Astera Labs' cash go? Astera Labs, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $74.6 M on assets over the last 3 years. Averaged over those years that is 2.9% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $74.6 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Astera Labs' P/E ratio, and how does it compare with its own history? Astera Labs, Inc.'s P/E is 88.3×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Astera Labs business getting better or worse? Astera Labs, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 11 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Astera Labs earn on its capital? Astera Labs, Inc. earned a ROE of 16% in FY25. That is up from a low of −34% in FY22. Its return on capital used (ROIC) is 41.0 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 25.7% net margin and 0.56× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 25.7% net margin × 0.56× asset turnover × 1.12× leverage (assets divided by equity) ≈ 16.1% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 66.4% − 25.4% = +41.0 percentage points. The 25.4% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. ## Does Astera Labs have too much debt? Astera Labs, Inc. has total debt of $44.4 M against shareholder equity of $1.7 B as of Jun 2026, so its debt is 0.03× its equity, which is very little. Year by year, that ratio went from 0.01 in FY22 to 0.02 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Astera Labs shareholding pattern? 5.1% of Astera Labs, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 1.9 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Astera Labs from balance-sheet trouble? For Astera Labs, Inc., the Z-score is 79.02. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 79.02 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Astera Labs rank in its industry? 52.1 out of 100, rank 10 of 27 in Semiconductors, with 71% of the evidence available. Astera Labs, Inc. scores 52.1 out of 100 against the 27 companies it is compared with in Semiconductors, ranking 10. Earnings are strong; relative strength in its sector is -7.2% and the one-year return is 35.2%. The four parts add up to the total exactly: 25 + 13.1 + 8.8 + 5.2 = 52.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Astera Labs compared with? Astera Labs ranks 10 of 27 Semiconductors companies on the 4-Factor Sector Score, with 52.1 out of 100. 1. [Texas Instruments Incorporated](https://www.sectoralpha.in/us/stocks/txn) TXN · turning · Most evidence points up · 85% evidence 79.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.4/35 · Revenue 20.3% · Profit 41% · Operating margin change 10.8 points · 95% evidence Capital efficiency 20.6/25 · ROCE 25.2% · Operating margin 47.5% · 76% evidence Valuation 14.1/20 · P/E 36.2× · PEG 0.89 · 65% evidence Relative strength 19.1/20 · Lead over its industry 19.5% · Lead over S&P 500 20.1% · 1 year 94.2% · 100% evidence · 2 of 12 weeks ahead Exact sum: 25.4 + 20.6 + 14.1 + 19.1 = 79.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Micron Technology, Inc.](https://www.sectoralpha.in/us/stocks/mu) MU · quiet · Most evidence points up · 75% evidence 76.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.9/35 · Revenue 100% · Profit 100% · Operating margin change 48.4 points · 95% evidence Capital efficiency 19.4/25 · ROCE 59% · Operating margin 80.7% · 76% evidence Valuation 11.4/20 · P/E 12.7× · PEG n/a · 15% evidence Relative strength 14.3/20 · Lead over its industry 21.8% · Lead over S&P 500 15.6% · 1 year 234.3% · 100% evidence · 4 of 12 weeks ahead Exact sum: 30.9 + 19.4 + 11.4 + 14.3 = 76 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Analog Devices, Inc.](https://www.sectoralpha.in/us/stocks/adi) ADI · turning · Most evidence points up · 85% evidence 73.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.6/35 · Revenue 33.6% · Profit 100% · Operating margin change 10.9 points · 95% evidence Capital efficiency 14.7/25 · ROCE 11.6% · Operating margin 39.5% · 76% evidence Valuation 11.9/20 · P/E 43.3× · PEG 1.33 · 65% evidence Relative strength 17.9/20 · Lead over its industry 6.4% · Lead over S&P 500 8.3% · 1 year 77.9% · 100% evidence · 3 of 12 weeks ahead Exact sum: 28.6 + 14.7 + 11.9 + 17.9 = 73.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [NVIDIA Corporation](https://www.sectoralpha.in/us/stocks/nvda) NVDA · quiet · Most evidence points up · 85% evidence 66.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.6/35 · Revenue 83.4% · Profit 100% · Operating margin change 5.4 points · 95% evidence Capital efficiency 21.6/25 · ROCE 71.3% · Operating margin 66.2% · 76% evidence Valuation 15.1/20 · P/E 26× · PEG 0.77 · 65% evidence Relative strength 9.6/20 · Lead over its industry -8.8% · Lead over S&P 500 -5.7% · 1 year 6.4% · 100% evidence · 4 of 12 weeks ahead Exact sum: 20.6 + 21.6 + 15.1 + 9.6 = 66.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Advanced Micro Devices, Inc.](https://www.sectoralpha.in/us/stocks/amd) AMD · losing its lead · Most evidence points up · 71% evidence 66.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.2/35 · Revenue 39.5% · Profit 100% · Operating margin change 19 points · 83% evidence Capital efficiency 11.1/25 · ROCE 9% · Operating margin 17.3% · 76% evidence Valuation 9.2/20 · P/E 132.2× · PEG n/a · 15% evidence Relative strength 18.6/20 · Lead over its industry 28.4% · Lead over S&P 500 24% · 1 year 109.3% · 100% evidence · 3 of 12 weeks ahead Exact sum: 27.2 + 11.1 + 9.2 + 18.6 = 66.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [NXP Semiconductors N.V.](https://www.sectoralpha.in/us/stocks/nxpi) NXPI · turning · Most evidence points up · 81% evidence 65.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.6/35 · Revenue 8.8% · Profit 38.5% · Operating margin change 4.6 points · 83% evidence Capital efficiency 17.1/25 · ROCE 16.2% · Operating margin 30.4% · 76% evidence Valuation 15.7/20 · P/E 23.5× · PEG 0.59 · 65% evidence Relative strength 16.0/20 · Lead over its industry 0.7% · Lead over S&P 500 3.4% · 1 year 29.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 16.6 + 17.1 + 15.7 + 16 = 65.4 · What this means: Relative strength against the index is 3.4%, and revenue and profit growth are weak. 7. [Broadcom Inc.](https://www.sectoralpha.in/us/stocks/avgo) AVGO · quiet · Evidence leans up · 85% evidence 62.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.2/35 · Revenue 48.7% · Profit 100% · Operating margin change 16.1 points · 95% evidence Capital efficiency 20.4/25 · ROCE 26% · Operating margin 54.3% · 76% evidence Valuation 5.8/20 · P/E 48.4× · PEG 5.06 · 65% evidence Relative strength 6.1/20 · Lead over its industry -19% · Lead over S&P 500 -15.9% · 1 year -6.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 30.2 + 20.4 + 5.8 + 6.1 = 62.5 · What this means: Earnings are strong; relative strength in its sector is -19% and the one-year return is -6.8%. 8. [Monolithic Power Systems, Inc.](https://www.sectoralpha.in/us/stocks/mpwr) MPWR · quiet · Evidence leans up · 81% evidence 55.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.2/35 · Revenue 28.6% · Profit -51.8% · Operating margin change 6.2 points · 83% evidence Capital efficiency 19.7/25 · ROCE 22.4% · Operating margin 31% · 76% evidence Valuation 5.6/20 · P/E 84.4× · PEG 3.48 · 65% evidence Relative strength 10.6/20 · Lead over its industry -5.9% · Lead over S&P 500 -4.5% · 1 year 31.7% · 100% evidence · 1 of 12 weeks ahead Exact sum: 19.2 + 19.7 + 5.6 + 10.6 = 55.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 9. [Qorvo, Inc.](https://www.sectoralpha.in/us/stocks/qrvo) QRVO · Too little evidence to rank firmly · 51% evidence 54.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.0/43.75 · Revenue -0.2% · Profit 100% · Operating margin change 11.6 points · 83% evidence Capital efficiency 14.3/31.25 · ROCE 12.1% · Operating margin 15.8% · 76% evidence Valuation 14.1/25 · P/E 20.7× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 26 + 14.3 + 14.1 = 54.4 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 10. Astera Labs, Inc. this page ALAB · quiet · Evidence leans up · 71% evidence 52.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.0/35 · Revenue 98.7% · Profit 100% · Operating margin change 2 points · 83% evidence Capital efficiency 13.1/25 · ROCE 15.5% · Operating margin 22.7% · 76% evidence Valuation 8.8/20 · P/E 224.1× · PEG n/a · 15% evidence Relative strength 5.2/20 · Lead over its industry -7.2% · Lead over S&P 500 -9.9% · 1 year 35.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 25 + 13.1 + 8.8 + 5.2 = 52.1 · What this means: Earnings are strong; relative strength in its sector is -7.2% and the one-year return is 35.2%. 11. [Microchip Technology Incorporated](https://www.sectoralpha.in/us/stocks/mchp) MCHP · quiet · Evidence leans up · 74% evidence 52.0 out of 100 Growth Capital Valuation Relative
12. [QUALCOMM Incorporated](https://www.sectoralpha.in/us/stocks/qcom) QCOM · turning · Evidence leans up · 81% evidence 51.5 out of 100 Growth Capital Valuation Relative
13. [Silicon Laboratories Inc.](https://www.sectoralpha.in/us/stocks/slab) SLAB · turning · Too little evidence to rank firmly · 58% evidence 50.6 out of 100 Growth Capital Valuation Relative
14. [Skyworks Solutions, Inc.](https://www.sectoralpha.in/us/stocks/swks) SWKS · breaking out · Evidence leans down · 64% evidence 48.7 out of 100 Growth Capital Valuation Relative
15. [Lattice Semiconductor Corporation](https://www.sectoralpha.in/us/stocks/lscc) LSCC · quiet · Too little evidence to rank firmly · 58% evidence 47.5 out of 100 Growth Capital Valuation Relative
16. [Credo Technology Group Holding Ltd](https://www.sectoralpha.in/us/stocks/crdo) CRDO · quiet · Evidence leans down · 75% evidence 47.1 out of 100 Growth Capital Valuation Relative
17. [ON Semiconductor Corporation](https://www.sectoralpha.in/us/stocks/on) ON · quiet · Too little evidence to rank firmly · 56% evidence 46.3 out of 100 Growth Capital Valuation Relative
18. [MACOM Technology Solutions Holdings, Inc.](https://www.sectoralpha.in/us/stocks/mtsi) MTSI · quiet · Evidence leans down · 68% evidence 45.9 out of 100 Growth Capital Valuation Relative
19. [Semtech Corporation](https://www.sectoralpha.in/us/stocks/smtc) SMTC · losing its lead · Evidence leans down · 67% evidence 44.2 out of 100 Growth Capital Valuation Relative
20. [Rambus Inc.](https://www.sectoralpha.in/us/stocks/rmbs) RMBS · quiet · Evidence leans down · 81% evidence 42.3 out of 100 Growth Capital Valuation Relative
21. [Tower Semiconductor Ltd.](https://www.sectoralpha.in/us/stocks/tsem) TSEM · quiet · Evidence leans down · 81% evidence 42.2 out of 100 Growth Capital Valuation Relative
22. [Marvell Technology, Inc.](https://www.sectoralpha.in/us/stocks/mrvl) MRVL · losing its lead · Evidence leans down · 67% evidence 41.8 out of 100 Growth Capital Valuation Relative
23. [STMicroelectronics N.V.](https://www.sectoralpha.in/us/stocks/stm) STM · quiet · Evidence leans down · 64% evidence 39.9 out of 100 Growth Capital Valuation Relative
24. [SiTime Corporation](https://www.sectoralpha.in/us/stocks/sitm) SITM · quiet · Evidence leans down · 64% evidence 39.5 out of 100 Growth Capital Valuation Relative
25. [Arm Holdings plc](https://www.sectoralpha.in/us/stocks/arm) ARM · quiet · Most evidence points down · 81% evidence 31.8 out of 100 Growth Capital Valuation Relative
26. [GLOBALFOUNDRIES Inc.](https://www.sectoralpha.in/us/stocks/gfs) GFS · quiet · Most evidence points down · 64% evidence 31.7 out of 100 Growth Capital Valuation Relative
27. [Intel Corporation](https://www.sectoralpha.in/us/stocks/intc) INTC · quiet · Most evidence points down · 75% evidence 31.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Semiconductors](https://www.sectoralpha.in/us/sectors/semiconductors), all 27 compared on one page. ## Which companies are close to Astera Labs in size? Astera Labs is the 18th largest of 59 Semiconductors companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: STMicroelectronics N.V., Microchip Technology Incorporated and United Microelectronics Corporation. Just below it: ON Semiconductor Corporation, Credo Technology Group Holding and GLOBALFOUNDRIES Inc. ### Semiconductors companies close in size

1. [STMicroelectronics N.V.](https://www.sectoralpha.in/us/stocks/stm) $41 billion
2. [Microchip Technology Incorporated](https://www.sectoralpha.in/us/stocks/mchp) $40.9 billion
3. [United Microelectronics Corporation](https://www.sectoralpha.in/us/stocks/umc) $39.4 billion
4. Astera Labs, Inc. $39.1 billion
5. [ON Semiconductor Corporation](https://www.sectoralpha.in/us/stocks/on) $27.7 billion
6. [Credo Technology Group Holding Ltd](https://www.sectoralpha.in/us/stocks/crdo) $25.6 billion
7. [GLOBALFOUNDRIES Inc.](https://www.sectoralpha.in/us/stocks/gfs) $22.1 billion

[All 59 Semiconductors companies, largest first](https://www.sectoralpha.in/us/sectors/semiconductors#all-companies)

### Companies close in size in other industries

1. [Teradyne, Inc.](https://www.sectoralpha.in/us/stocks/ter) $39.2 billion · Semiconductor Equipment & Materials
2. [Vodafone Group Public Limited Company](https://www.sectoralpha.in/us/stocks/vod) $39.1 billion · Telecom Services
3. Astera Labs, Inc. $39.1 billion
4. [Take-Two Interactive Software, Inc.](https://www.sectoralpha.in/us/stocks/ttwo) $39.1 billion · Electronic Gaming & Multimedia
5. [WEC Energy Group, Inc.](https://www.sectoralpha.in/us/stocks/wec) $38.9 billion · Utilities - Regulated Electric

## What else do people ask about Astera Labs? ### What were Astera Labs's latest quarterly results? Astera Labs, Inc. reported revenue of $392 M and net profit of $153 M for the Jun 2026 quarter. Revenue rose 104.5% and profit rose 198.9% compared with a year earlier. Earnings per share were $0.83. The operating margin was 22.7%, 2.0 percentage points higher than a year earlier (as of 4 November 2026). ### What is Astera Labs's market cap? Astera Labs, Inc.'s market capitalisation is $39.1 B at a stock price of $223.73. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Astera Labs performing? Astera Labs, Inc.'s share price has been moving sideways for 1 weeks. In its latest quarter, revenue rose 104.5% and profit rose 198.9% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 12 weeks running (as of 4 November 2026). ### Will Astera Labs's stock price go up? This page does not forecast Astera Labs, Inc.'s stock price. What it shows instead: the stock price is $223.73, and it has been moving sideways for 1 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026). ### Where is Astera Labs in its business cycle? Astera Labs, Inc.'s FY25 operating margin was 20.3%, against a 4-year range of −75.4% to 20.3%: the middle of its own range, neither a peak nor a low. The latest quarter was 22.7%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Astera Labs story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Astera Labs a stock worth studying right now? What the numbers show: Astera Labs, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ## Lists

- Nasdaq 100 companies: https://www.sectoralpha.in/nasdaq-100-stocks
- US tech stocks: https://www.sectoralpha.in/us-tech-stocks

This is research, not advice. We’re not SEBI-registered.